FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients

Settlement resolves FTC lawsuit alleging that Express Scripts’ conduct resulted in artificially inflated insulin drug prices

The Federal Trade Commission secured a landmark settlement with one of the nation’s largest pharmacy benefit managers (“PBMs”), Express Scripts, Inc., and its affiliated entities (collectively “ESI”).View Press Release